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Dear Sir 
I would like to draw your attention that I submit the internship report entitled “Ratio 
Analysis & Financial Performance of JMI Syringes & Medical Devices Ltd.” for your kind 
evaluation as part of my requirement for completing the MBA degree from BRAC 
University.  
 
This report helped to collect convenient and very significant knowledge about the 
surgical device market in Bangladesh as a whole. This report is based on the financial 
highlights and activities conducted by JMI syringe & Medical Device Co. Ltd. While 
conducting the report, I have learnt business market development strategies, financial 
situation analysis and evaluation. 
I have tried to be extremely meticulous in preparing this report despite the various 
limitations faced as very limited information about surgical industry. I sincerely hope that 
this report fulfils the objectives and requirements of the MBA program and that it finds 
your acceptance. I would also like to express my gratitude for your guidance, support 
and time and should you require any elaboration on any issue, I shall be glad to oblige. 
 
Sincerely yours 
Md. Rajibul Haque         ID: 13164096 
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Executive Summary 
 
Surgical Device market in Bangladesh has great prospect for the local manufacturer of 
surgical device. More than 30,000 surgical devices are available in Bangladesh. Almost 
all devices are exported from foreign country. So I can tell surgical device market as the 
unexplored market. Only few major companies are providing surgical devices in 
Bangladesh. If the companies manufacture more surgical device then it generate huge 
profit to them. It also creates more empowerment and also contributes to our national 
economy.  
JMI Syringes & Medical Devices Ltd. has various kinds of surgical product, although it is 
very difficult and risky for surgical device provider to develop new product, JMI has 
eleven products. The company's age is not very old in comparison of its competitor. But 
still the companies are doing well in surgical device market in Bangladesh.  
JMI Syringes & Medical Devices Limited has received tremendous response by 
institution buyer and dealers. Institution buyers have gained confidence in their products 
for quality and economics. This business shows considerable promise in contributing to 
the national economy of Bangladesh. This report focuses on JMI's financial strategies, 
promotional activities, and position in the market. 
The report continues to assess the organization through a Ratio analysis and some 
other financial issues. The suggested ways of overcoming those issues and challenges 
have been elaborated in the recommendations section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Surgical Device market in Bangladesh has great prospect for the local manufacturer of 
surgical device. More than 30,000 surgical devices are available in Bangladesh. Almost 
all devices are exported from foreign country. So we can tell surgical device market as 
the unexplored market. Only a few companies are providing surgical devices in 
Bangladesh.  
JMI has various kinds of surgical product, although it is very difficult and risky for 
surgical device provider to develop new product, JMI has eleven products. The 
company's age is not very old in comparison of its competitor. But still the companies 
are doing well in surgical device market in Bangladesh.  
JMI Syringe & Medical Device Limited has received tremendous response by 
institutional buyers and dealers. Institutional buyers have gained confidence in their 
products for quality and economics. This business shows considerable promise in 
contributing to the national economy of Bangladesh. This report focuses on JMI's 
syringe & other medical devices, their various financial strategies, promotional activities, 
and their position in the market in comparison to the market leader and so on. 
JMI charges cost plus pricing for some of his products and for unique product like Auto 
Disposable syringe and urine drainage bag they charges skimming pricing. They have 
also promotion strategy like other surgical device company in Bangladesh. The 
promotion campaign is inspiring the doctors and their patient to use safe syringe, 
attending different seminar, fair related to pharmaceutical product. But due to the Govt. 
prohibition they can't promote their product by the mass media.  
This report also covers the findings and analysis based on the response of the users of 
surgical device. In addition, it will also help them to understand the needs and wants of 
their target audience and to provide them with the best possible service.  
Based on the current status on JMI Syringe & Medical Device Company Ltd, it can be 
said that it has tremendous potential to be the market leader. Proper planning and 
implementation of effective strategies will help them to achieve this objective within a 
short span of time. 
 
 
 
 
 
 
 
 
 
 
History 
 
JMI Syringes & Medical Devices Ltd. was incorporated as a Private Limited Company 
on 5th April, 1999 in Bangladesh with an Authorized Capital of Tk. 6,00,00,000/- 
divided into 600,000 ordinary shares of Tk. 100/=each under the Companies Act., 1994. 
Subsequently the Company increased its Authorized Capital to Tk.30,00,00,000/- and 
reduced the denomination of the shares from Tk. 100/= to Tk. 10/= as per Extra 
Ordinary General Meeting held on February 04, 2002 and was converted into a Public 
Limited Company as per Extra Ordinary General Meeting held on August 20, 2002. 
Again the Company reverted its denomination of the shares from Tk. 10/= to Tk. 100/= 
as per Extra Ordinary General Meeting held on May 05, 2003 and went for public issue 
during that year. Company's share is listed with the Dhaka and Chittagong Stock 
Exchange Ltd. The Company has changed its name from JMI-Bangla Co. Ltd. to JMI 
Syringes & Medical Devices Ltd. by an Extra-Ordinary resolution passed on October 
01, 2009 and this change has been approved by the Registrar of Joint Stock 
Companies & Firms on April 15, 2010.The Company has changed an authorized capital 
from Tk. 30 Crore to Tk. 100 Crore and reverted its denomination of the share from Tk. 
100/= to Tk. 10/= each. So that the Ordinary Shares of the Company has also been 
changed from 30 Lac to 10 Crore. It was approved by the shareholder an Extra Ordinary 
General Meeting held on 2th September 2012 and also approved by the Registrar of 
Joint Stock Companies on 14-11-2012. 
As a global medical & surgical appliances company, JMI’s commercial success 
depends on it’s creating innovative new medical devices and making these accessible 
to as many people who need them as possible. 2012 was characterized by a 
challenging global economic & political climate. Despite this, JMI has continued to make 
good progress in strategy to grow its business in a sustainable way, deliver new medical 
devices and surgical products that are valued by those who use them. All of this has 
allowed JMI to deliver significant returns to shareholders. 
 
 
 
 
 
 
 
 
 
 
 
 
Products 
 
JMI Disposable Syringe: 
Versatile forms. 
Luer lock and Luer slip types. 
Leading local & international health care institutions 
of the country are the major users. 
 
JMI Auto Disable (AD) Syringe: 
(WHO Recommended brand) 
Manufactured under the technical collaboration with 
Star Syringe Ltd., UK. 
Prevents transmission of life threatening diseases 
(HIV/AIDS, Hepatitis, etc.) 
JMI is the major provider to EPI, DGFP, CMSD and 
Helm GMBH (Germany). 
 
JMI Insulin Syringe: 
Superior needle sharpness and low dead space for 
patient-comfort and accurate dosing. 
 
JMI Scalp Vein Set: 
Specially designed, user friendly brand with superior 
needle sharpness. 
First global standard brand of Bangladesh. 
 
JMI IV Cannula: 
Unique design with FEP radio opaque, kink resistant 
and specially tapered catheter for easy vein 
puncture with minimum trauma. 
First Bangladeshi brand of international standard. 
 
JMI Disposable Needle: 
Laser beam inspected hypodermic single use 
needle with superior sharpness. 
 
 
 
 
 
 
JMI Infusion Set: 
Compliance with international standard is validated 
through bio-compatibility test conducted by Toxicon 
Corporation, a prominent performing laboratory of 
USA. 
 
JMI Blood Transfusion Set: 
Manufactured with 200 pm mesh filter in drip 
chamber ensuring smooth blood flow and optimum 
filtration of fibrin clots and other particulate debris. 
First international standard band of Bangladesh. 
 
JMI Intra Uterine Contraceptive Device 
(IUD) –  
Copper T 380A: 
Convenient, hormone free, safe and long lasting 
contraceptive device with high global 
recommendation. 
First time introduction in Bangladesh 
 
JMI First Aid Bandage (PVC): 
Water proof, non stick, flexible and porous PVC bandage. 
 
JMI Safety Box: 
Ensures safe disposal of sharp and used medical 
wastes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Organizational Organogram:  
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Mission... 
"Manufacture and supply of quality medical & surgical appliances by promoting safe 
health care practices & subsequently establishing family welfare among the people 
through innovative technology". 
The Management Mission represents the purpose of presence, social mission and 
domain identity of the JMI. 
 
Vision... 
"Attain leadership as manufacturer of medical & surgical appliances to provide services 
and assistance to health and family welfare sector in the country from global 
prospective.” 
The Management Mission represents the JMI stance towards the goal with a long-term 
perspective, based on our management vision. 
 
Values... 
"We value our shareholders by ensuring fair return on their investment through 
generating stable profit ". 
 
Goal... 
"Ensuring quality and safety of all devices manufactured in the country from JMI 
Group through upgrading the quality of products to match with the global 
standard and availability at affordable price". 
 
Objectives... 
Consistent improve product lines and provide uninterrupted service to building activities 
for a healthier nation to gain economic productivity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Job Description: 
 
Job Title: Senior Accounts Officer 
Department:  Finance & Accounts. 
Reports to: Director, Finance. 
 
The following positions report to this position: 
 Accounts Executive (Jr. Accounts Executive) 
 Marketing Promotion Officer (Collection Officer) 
 Executives, Marketing & Sales. 
 
Summary of Position: 
 
Maintain daily cash & bank related job with opening L/C and other L/C related 
corresponding. Communicate with existing clients for sales collection, guide accounting 
clerical staff by coordinating activities and answering questions. Ensure collections are 
steady from trade debtors and deliveries of goods are made as per client’s requirement.  
Prepare special financial reports by collecting, analyzing, and summarizing account 
information and trends Seek for customer feedback and develop relationship. Notify 
director if major problems regarding payment from clients occur. Forecast sales, ensure 
forecasted collection & supervise the preparation of weekly & monthly bills and delivery.  
 
Duties & Responsibilities: 
 
Prepares asset, liability, and capital account entries by compiling and analyzing 
account information.  
Documents financial transactions by entering account information.  
 
Summarizes current financial status by collecting information; preparing balance 
sheet, profit and loss statement, and other reports.  
 
ncies by collecting and analyzing account information.  
 
 
ursements.  
 
 
 
 
information and trends.  
Maintains customer confidence and protects operations by keeping financial    
information confidential.  
am effort by accomplishing related results as needed. 
 Review financial data that affects department’s profits. 
 Maintain purchase order files, client’s files, delivery sheets and monthly bill files. 
 
Different Aspects of Job performance: 
 
I am measure by the number of documents of L/C we have handled each months as an 
Executive Officer of JMI Syringes & Medical Devices Ltd. I am also measured by the 
handling of the L/C without any fail and assisting our documentations team (commercial 
team) smoothly and error freely. It is also mandatory that I maintain good relationship 
with suppliers and our buyers. Everyday different types of reports come for various L/C 
related issues and I need to take immediate action to solve if there are any 
discrepancies, forward it to right person. 
 
Critical observations and recommendations: 
 
 Jmi has to pay a huge amount of loan interest for bank loan and others hand 
loan. But the directors don't get bother about it. If the company can able to 
reduce some of its loan then profit will go higher. 
 Clients outside Dhaka mostly are the biggest defaulters in terms of payment 
since some of the clients have long business relationship and with the company 
and do not pay 50% advance payment for orders but gradually pay after delivery 
is made. Thus these companies create a problem in forecasting monthly 
collection.  
 Most clients from outside Dhaka claim that some portion of the goods delivered 
were damaged or unusable. In such cases instant quality checking is impossible 
and hence payments from clients are delayed or has to be compromised. 
 
 
 
 
 
 
 
 
 
 
Description of the Project 
JMI Group Limited is the one of the leading Manufacturer of surgical devices in 
Bangladesh and it has been continuously in competitive position among all national and 
multinational companies since 2003. But its journey to the growth and prosperity was 
very tough after the inception in 1999. This report shows various financial strategies, 
promotional activities and position in the market in comparison to the market leader and 
so on. While preparing this report, I had a great opportunity to have an in depth 
knowledge of all the Financial activities of JMI Syringe & Medical Devices Company Ltd. 
It also helped me acquire a firsthand perspective of one of the leading Manufacturer of 
surgical devices company in Bangladesh. It must be also noted that the data used here 
is truly and strictly confidential and no one can use its components in full or partial. I 
would like to give thanks to everyone who has helped and encouraged me in the 
process of preparing the report. 
 
Objective:: 
The main objective of this report is to know about and analyze the financial strategies of 
the company, analyzing the current market and make possible recommendation about 
the company. 
 
 To understand the structure of JMI.  
 
 
 
financial report.  
ness market.  
 
 
Methodology:: 
 
Sources of Data:  
The information I needed to complete this report were collected from the following 
sources:  
 
Primary Sources:  
Primary data are collected through sample survey and interviews with the concerned 
party. It included the fresh or completely new data sources collected for a specified 
purpose, such as interviews, observations etc.  
 
 
Practical work exposures from different sections of the company  
 
 
 
 
 
 
Secondary Sources:  
Secondary data are collected through gathering of the published materials (annual 
report) of the company, industry sales report from the concerned authority. It included 
sources of existing/published data. 
 
 
e.  
 
 
 
 
 
 
Limitation:: 
 
During the study of the report we have faced following problems- 
 Time is not enough for such an extensive study.  
 Information relating to the survey is very sensitive that is why secondary data 
have been used in some extent. 
 Sometimes it is difficult to understand a few accounting and financial terms which 
could otherwise be incorporated sufficiently in preparing the report. 
  I have to be aware that ratio analysis is widely used as a performance indicator, 
but it does have its limitations too. For instance, accounts show only the 
monetary aspects of the business. They do not show management or staff 
strengths or weaknesses. So ratio analysis ignores this aspect of the 
performance as well. 
 
 
 
 
Bangladesh Surgical Market: 
Surgical device industry has grown in Bangladesh in the last two decades at a 
considerable rate. Its healthy growth supports development of auxiliary industries for 
producing glass bottles, plastic containers, aluminium collapsible tubes, aluminium PP 
caps, infusion sets, disposable syringes, and corrugated cartons. Some of these 
products are also being exported. Printing and packaging industries and even the 
advertising agencies consider pharmaceutical industry as their major clients and a key 
driving force for their growth.  
The sector consistently creates job opportunities for highly qualified people. Many 
established entrepreneurs of today started with pharmaceutical companies in the 
country. Pharmaceutical companies are either directly or indirectly contributing largely 
towards raising the standard of healthcare through enabling local healthcare personnel 
to gain access to newer products and also to latest drug information.  
Following the Drug (Control) Ordinance of 1982, some of the local pharmaceutical 
companies improved range and quality of their products considerably. The national 
companies account for more than 65% of the pharmaceutical business in Bangladesh. 
However, among the top 20 companies of Bangladesh 6 are multinationals. Almost all 
the lifesaving imported products and new innovative molecules are channeled into and 
marketed in Bangladesh through these companies. Multinational and large national 
companies generally follow current good manufacturing practices (GMP) including 
rigorous quality control of their products. The Drug Act of 1940 and its rules formed the 
basis of the country’s drug legislation. Unani, ayurvedic, homeopathic and biochemic 
medicines were exempted from control under the legislation. The pharmaceutical 
industry was dominated by the foreign companies at that time. Even in the allopathic 
market there were extemporaneous preparations dispensed from retail pharmacies.  
The surgical device industry, however, like all other sectors in Bangladesh, was much 
neglected during Pakistan regime. Most multinational companies had their production 
facilities in West Pakistan. With the emergence of Bangladesh in 1971, the country 
inherited a poor base of surgical device industry. For several years after liberation, the 
government could not increase budgetary allocations for the health sector. Millions of 
people had little access to essential life saving medicines. With the promulgation of the 
Drug (Control) Ordinance of 1982 many medicinal products considered harmful, useless 
or unnecessary got removed from the market allowing availability of essential drugs to 
increase at all levels of the healthcare system. Increased competition helped maintain 
prices of selected essential drugs at the minimum and affordable level.  
In 1981, there were 166 licensed surgical device manufacturers in the country, but local 
production was dominated by eight multinational companies (MNCs) which 
manufactured about 75% of the products. There were 25 medium sized local companies 
which manufactured 15% of the products and the remaining 10% were produced by 
other 133 small local companies. All these companies were mainly engaged in 
formulation out of imported raw materials involving an expenditure of Tk 600 million in 
foreign exchange. In spite of having 166 local pharmaceutical production units, the 
country had to spend nearly Tk. 300 million on importing finished medicinal products. A 
positive impact of the Drug (Control) Ordinance of 1982 was that the limited available 
foreign currency was exclusively utilized for import of pharmaceutical raw materials and 
finished drugs, which are not produced in the country. The value of locally produced 
medicines rose from Tk. 1.1 billion in 1981 to Tk. 16.9 billion in 1999. At present, 95% of 
the total demand of medicinal products is met by local production. Local companies 
(LCs) increased their share from 25% to 70% on total annual production between 1981 
and 2000. 
In 2000, there were 210 licensed allopathic drug-manufacturing units in the country, out 
of which only 173 were on active production; others were either closed down on their 
own or suspended by the licensing authority for drugs due to non compliance to GMP or 
drug laws. They manufactured about 5,600 brands of medicines in different dosage 
forms. There were, however, 1,495 wholesale drug license holders and about 37,700 
retail drug license holders in Bangladesh. 
Physical distribution of pharmaceuticals in Bangladesh has evolved in a unique way. 
Unlike other countries Bangladesh pharmaceutical industry is more retail oriented and 
bulk of distribution is done by the companies themselves. Pharmaceutical companies 
distribute their products from their own warehouses located in different parts of the 
country, as no professional distribution house is available. Wholesalers play a limited 
role in this regard since companies supply goods to both retailers and wholesalers. 
Export of pharmaceutical products is still in an infant stage, although a number of 
private pharmaceutical companies have already entered the export market with their 
basic materials and finished products.  
The annual per capita drug consumption in Bangladesh is one of the lowest in the 
world. However, the industry has been a key contributor to the Bangladesh economy 
since independence. With the development of healthcare infrastructure and increase of 
health awareness and the purchasing capacity of people, this industry is expected to 
grow at a higher rate in future. Healthy growth is likely to encourage the pharmaceutical 
companies to introduce newer drugs and newer research products, while at the same 
time maintaining a healthy competitiveness in respect of the most essential surgical 
devices.   
 
 
 
Financial statement analysis:  
A sustainable business and mission requires effective planning and financial 
management. Ratio analysis is a useful management tool that will improve the 
understanding of financial results and trends over time, and provide key indicators of 
organizational performance. Managers will use ratio analysis to pinpoint strengths and 
weaknesses from which strategies and initiatives can be formed. Funders may use ratio 
analysis to measure the results against other organizations or make judgments 
concerning management effectiveness and mission impact. It is defined as the process 
of identifying financial strengths and weaknesses of the firm by properly establishing 
relationship between the items of the balance sheet and the profit and loss account. The 
process of reviewing and evaluating a company’s financial statements (such as the 
balance sheet or profit and loss statement), thereby gaining an understanding of the 
financial health of the company and enabling more effective decision making. Financial 
statements record financial data; however, this information must be evaluated through 
financial statement analysis to become more useful to investors, shareholders, 
managers and other interested parties. Financial statement analysis is an evaluative 
method of determining the past, current and projected performance of a company.  
  
For ratios to be useful and meaningful, they must be:  
o Calculated using reliable, accurate financial information  
o Calculated consistently from period to period  
o Used in comparison to internal benchmarks and goals  
o Used in comparison to other companies in the industry  
o Viewed both at a single point in time and as an indication of broad trends and issues 
over time  
o Carefully interpreted in the proper context, considering there are many other important                            
factors and indicators involved in assessing performance.  
o To provide analytical information to all interested parties.  
o To justify and analyze the earning capacity of the firm  
o To justify and analyze the financial position of the firm  
o To evaluate operations of the firm.  
o To evaluate progress of the business of the firm  
o To utilize resources properly and effectively  
o To analyze and evaluate management efficiency. 
 
 
 
 
 
JMI Syringes & Medical Devices Ltd. 
Statement of Profit & Loss Account 
For the Year ended 31st December 2014 
 
Particulars Notes   
 Amount                
31st Dec 2014  
  
  
   
  
Revenue from Net Sales 
  
       1,199,135,889.00    
Local Sales  
 
  657,945,099.00  
 
  
Export Sales 
 
  541,190,790.00  
 
  
Less: Cost of Goods Sold 9 
 
           830,279,284.00    
Gross Profit 
  
           368,856,605.00    
Less: Operating Expense 
  
           102,780,678.00    
Administration Expense 10      52,327,254.00  
 
  
Selling, Marketing & Distribution Expense 11      50,453,424.00  
 
  
  
  
           266,075,927.00    
Add. Other Income 12 
 
                
1,694,552.00    
  
  
           267,770,479.00    
Less. Financial Cost 13 
 
           193,008,017.00    
Income Before Adjustment of WPPF 
  
             74,762,462.00    
Less. Worker Profit Participation Fund 14 
 
                
3,560,117.00    
Net Profit Before Adjustment of Income Tax 
  
             71,202,345.00    
Less. Income Tax Expense 15 
 
             22,194,857.00    
Net Profit / Net Income 
  
             49,007,488.00    
  
   
  
Earnings Per Share (EPS) 
  
                               
4.46    
          
 
 
 
 
 
 
 
 
 
 
 
 
JMI Syringes & Medical Devices Ltd. 
Statement of Financial Position 
As at 31st December 2014 
 
Particulars Notes   
 Amount                
31st Dec 2014  
  
   Assets 
     
   
Non Current Assets 
  
  
1,049,076,976.00  
Property, Plant & Equipment 1 
  
1,049,076,976.00  
 
Current Assets: 
  
     
794,736,156.00  
Cash & Cash Equivalents 
 
      
45,227,668.00  
 
Inventories 3 
     
475,865,683.00  
 
Advance Deposits & Prepayments 
 
       
49,183,190.00  
 
Advance Income Tax 4 
       
93,889,228.00  
 
Accounts Receivable 
 
     
130,570,387.00  
   
   
Total Assets 
  
 
1,843,813,132.00  
  
     
   Equity & Liabilities 
     
   
Equity 
  
     
537,505,033.00  
Share Capital (Issued, Subscribed & Paid up 
Capital) 
 
    
110,000,000.00  
 
Tax Holiday Reserve 5 
       
12,119,070.00  
 
Retained Earnings 6 
       
84,746,274.00  
 
Revalution Reserve 2 
     
330,639,690.00  
 
Non Current Liabilities 
  
     
653,277,756.00  
Project & Term Loan (Non Current Maturity) 
 
    
551,228,652.00  
 
Lease Finance 
 
       
79,288,314.00  
 
Deferred Tax Liability 7 
       
22,760,790.00  
 
Current Liabilities 
  
      
653,030,343.00  
Current Maturity Project Loans 
 
    
113,299,802.00  
 
Current Maturity Lease Finance 
 
       
45,645,302.00  
 
Short Term Loan 
 
     
247,763,789.00  
 
Sister Concern Loan 
 
       
41,415,960.00  
 
Dividend Payable 8 
         
3,149,605.00  
 
Accrued Interest Payable 
 
       
68,869,050.00  
 
Creditors & Others Payable 
 
     
132,886,835.00  
   
   
Total Equity & Liabilities 
  
 
1,843,813,132.00  
  
   
Net Assets Value Per Share     
                       
48.86  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
JMI Syringes & Medical Devices Ltd. 
Cash Flow Statement 
For the Year ended 31st December 2014 
Particulars Notes   
  Amount                
31st Dec 2014  
  
  
   
  
Cash Flow From Operating Activities 
   
  
Collections from Customers & Others 
 
   1,251,889,895.00  
 
  
Payment to Suppliers & Others 
 
    (966,533,770.00) 
 
  
AIP Paid 
 
              
(39,915,685.00) 
 
  
Net Cash Flow from Operating Activities 
  
              
245,440,440.00    
  
   
  
Cash Flow From Investing Activities 
   
  
Acquisition of Non Current Assets 
 
         
(21,984,579.00) 
 
  
Disposable of Vehicles 
 
                   
650,000.00  
 
  
Net Cash Flow from Investing Activities 
  
             
(21,334,579.00)   
  
   
  
Cash Flow From Financing Activities 
   
  
Project & Term Loan Received 
 
      
653,349,524.00  
 
  
Project & Term Loan Paid 
 
 (153,054,282.00) 
 
  
Lease Finance Loan Received 
 
         
53,000,000.00  
 
  
Lease Finance Loan Paid 
 
       
(30,617,356.00) 
 
  
Short Term Loan Received 
 
       
178,276,332.00  
 
  
Short Term Loan Paid 
 
    (503,856,289.00) 
 
  
Director & Sister Concern Loan Received 
 
         
31,962,305.00  
 
  
Director & Sister Concern Loan Paid 
 
    (370,957,270.00) 
 
  
Dividend & Dividend Tax Paid 
 
       
(15,938,175.00) 
 
  
Interest & Bank Charge Paid 
 
    (124,138,967.00) 
 
  
Net Cash Flow from Financing Activities 
  
           
(281,974,178.00)   
Net Cash Surplus / (Deficit) for the year (2013) 
  
              
(57,868,317.00)   
Cash and Bank Balance at the beginning of the year 
  
              
103,095,986.00    
Cash and Bank Balance at the end of the year 
  
                
45,227,669.00    
          
 
 
 
Purpose and use of ratio analysis:  
A primary advantage of ratios is that they can be used to compare the risk and return 
relationships of firms of different sizes. Ratios can also provide a profile of a firm, its 
economic characteristics and competitive strategies, and its unique operating, financial 
and investment characteristics. However, be deceptive as it ignores differences among 
industries, the effect of varying capital structure and differences bin accounting and 
reporting methods. Given these differences, changes in a ratio and variability over time 
may be more informative than the level of the ratio at any point in time. 
 
Four broad categories measure the different aspects of risk and return relationships: 
1. Activity analysis – evaluates revenue and output generated by the firm’s assets 
2. Liquidity analysis – measures the adequacy of a firm’s cash resources to meet its 
near-term cash obligations. 
3. Long-term debt and solvency analysis – examines the firm’s capital structure, 
including the mix of its financing sources and the ability of the firm to satisfy its long-
term debt and investment obligations. 
4. Profitability analysis – measures the income of the firm relative to its revenues and 
invested capital. 
 
Importance of ratio analysis:  
1. Ratio analysis simplifies and summarizes complex accounting figures and arranges 
them systematically for use by different parties. 
2. It measures and evaluates the financial condition and operating effectiveness of a 
business institution. 
3. It aids in diagnosing the financial health of the business. By calculating and studying 
different ratios one can analyze the weaknesses and strengths of the business. 
4. By analyzing the past performance future can be projected and predicted. 
5. It promotes coordination by studying the efficiency and deficiency of different parts of 
the business. 
6. It assists in communication by conveying necessary information to all related parties. 
7. It facilitates the effective control of business operations by means of appraisal targets 
both physical and monetary. 
 
 
 
 
 
 
 
 
Types of ratio:  
A: Liquidity ratio - ratios that show the relationship of a firm’s cash and other current 
assets to its current liabilities. This includes (i) Current ratio (ii) Quick ratio 
B: Asset management ratio - A set of ratios that measures how effectively a firm is 
managing its assets.  This includes (i) Inventory turnover ratio (ii) Days sales 
outstanding or average collection period (iii) Fixed asset turnover (iv) Total asset 
turnover 
C: Debt management ratio - ratios that show the relationship of a firm’s total debt, 
equity and total assets. This includes (i) Debt ratio (ii) Debt-equity ratio (iii) Times 
interest earned ratio (iv) Fixed charge coverage ratio   
D: Profitability ratio - a group of ratios showing the effect of liquidity, asset 
management and debt management on operating results. This includes (i) Gross profit 
margin (ii) Operating profit margin (iii) Net profit margin (iv) Return on total asset (v) 
Return on common equity (vi) Operating expense ratio 
E: Market value ratio – a set of ratios that relate the firm’s stock price to its earnings 
and book value per share. Ratios under this are (i) Price/earnings ratio (ii) Market 
value/book value ratio 
 
Ratios may be classified into the following types depending upon the statements from 
which they are derived: 
  
(a) Balance sheet ratio: Ratios calculated on the basis of the figures drawn from the 
balance sheet. Current ratio, Quick ratio etc.  
(b) Profit and loss account ratio: Ratios calculated on the basis of the figures drawn 
from profit and loss account. Gross profit ratio, net profit ratio etc.  
(c) Composite ratios: Ratios calculated on the basis of the figures drawn from both 
balance sheet and profit and loss account. Sales turnover, accounts receivable turnover 
etc.  
Ratios as a tool of financial analysis may be classified into the following types:  
(a) Short-term solvency ratios – Current ratio and quick ratio etc.  
(b) Financial structure ratios – Debt to equity ratio and debt ratio etc.  
(c) Profitability ratios – Return on capital employed and return on total assets etc.  
 
 
 
 
 
 
 
 
Advantage of Ratio Analysis 
 
Ratio analysis is necessary to establish the relationship between two accounting figures 
to highlight the significant information to the management or users who can analyze the 
business situation and to monitor their performance in a meaningful way. The following 
are the advantages of ratio analysis: 
(1) It facilitates the accounting information to be summarized and simplified in a required 
form. 
(2) It highlights the inter-relationship between the facts and figures of various segments 
of business. 
(3) Ratio analysis helps to remove all type of wastages and inefficiencies. 
(4) It provides necessary information to the management to take prompt decision 
relating to business. 
(5) It helps to the management for effectively discharge its functions such as planning, 
organizing, controlling, directing and forecasting. 
(6) Ratio analysis reveals profitable and unprofitable activities. Thus, the management 
is able to concentrate on unprofitable activities and consider to improve the efficiency. 
(7) Ratio analysis is used as a measuring rod for effective control of performance of 
business activities. 
(8) Ratios are an effective means of communication and informing about financial 
soundness made by the business concern to the proprietors, investors, creditors and 
other parties. 
(9) Ratio analysis is an effective tool which is used for measuring the operating results 
of the enterprises. 
(10) It facilitates control over the operation as well as resources of the business. 
(11) Effective co-operation can be achieved through ratio analysis. 
(12) Ratio analysis provides all assistance to the management to fix responsibilities. 
(13) Ratio analysis helps to determine the performance of liquidity, profitability and 
solvency position of the business concern. 
 
 
 
 
 
 
 
 
 
 
 
Limitations of Ratio Analysis 
 
Ratio analysis is one of the important techniques of determining the performance of 
financial strength and weakness of a firm. Though ratio analysis is relevant and useful 
technique for the business concern, the analysis is based on the information available in 
the financial statements. There are some situations, where ratios are misused, it may 
lead the management to wrong direction. The ratio analysis suffers from the following 
limitations: 
1. Ratio analysis is used on the basis of financial statements. Number of limitations of 
financial statements may affect the accuracy or quality of ratio analysis. 
2. Ratio analysis heavily depends on quantitative facts and figures and it ignores 
qualitative data. Therefore this may limit accuracy. 
3. Ratio analysis is a poor measure of a firm's performance due to lack of adequate 
standards laid for ideal ratios. 
4. It is not a substitute for analysis of financial statements. It is merely used as a tool for 
measuring the performance of business activities. 
5. Ratio analysis clearly has some latitude for window dressing. 
6. It makes comparison of ratios between companies which is questionable due to 
differences in methods of accounting operation and financing. 
7. Ratio analysis does not consider the change in price level, as such, these ratio will 
not help in drawing meaningful inferences. 
 
Operational Highlights 
 
 
   Particulars 2014 2013 2012 2011 
Revenue from net sales 1,19,91,35,889.00 83,92,84,712.00 57,80,50,158.00 49,68,04,636.00 
Gross Profit   36,88,56,605.00  26,63,08,701.00   18,26,72,264.00 15,49,52,271.00 
Operating Profit   26,60,75,928.00  18,38,97,671.00   12,43,38,895.00 10,03,68,525.00 
Net Profit Before Tax     7,12,02,345.00    4,62,90,249.00     3,50,24,983.00   3,51,58,334.00 
Net Profit After Tax     4,90,07,488.00    3,24,19,067.00     1,23,41,080.00   1,15,70,605.00 
Earnings Per Share                      4.46 2.95 1.12 1.05 
Total Asset 2,18,44,25,373.00 2,20,97,16,398.00 1,48,97,96,245.00 94,21,30,075.00 
Shareholders' Equity    53,75,05,033.00    50,63,21,664.00    50,42,20,721.00 14,11,10,225.00 
 
 
 
  
 
 
 
 
Financial Highlights 
 
 
   Particulars 2014 2013 2012 2011 
Authorized Capital 
   
1,000,000,000.00  
    
1,000,000,000.00  
     
1,000,000,000.00  
     
300,000,000.00  
Paid Up Capital  
       
110,000,000.00  
        
110,000,000.00  
        
110,000,000.00  
     
110,000,000.00  
Revenue From Net 
Sales 
     
1,199,135,889.00  
      
839,284,712.00  
      
578,050,158.00  
    
496,804,636.00  
Export Earnings 
       
541,190,790.00  
        
217,077,591.00  
        
110,623,500.00  
                
57,793.00  
Gross Profit 
     
368,856,605.00  
      
266,308,701.00  
      
182,672,263.00  
    
154,952,271.00  
Operating Profit 
     
266,075,928.00  
      
183,897,671.00  
      
124,338,895.00  
    
106,368,525.00  
Net Profit Before Tax 
       
71,202,345.00  
        
46,290,249.00  
        
36,676,521.00  
      
35,158,334.00  
Net Profit After Tax 
       
49,007,488.00  
        
32,419,067.00  
        
27,555,578.00  
      
11,570,605.00  
Fixed Assets at Cost 
   
1,389,689,217.00  
    
1,369,344,892.00  
     
1,293,065,410.00  
     
822,692,200.00  
Current Asset 
       
794,736,156.00  
        
840,371,506.00  
        
444,439,347.00  
     
311,464,343.00  
Total Asset 
   
2,184,425,373.00  
   
2,209,716,398.00  
    
1,742,459,370.00  
  
1,140,762,693.00  
Non Current Liability 
       
653,277,756.00  
        
162,167,422.00  
        
128,647,403.00  
     
193,637,139.00  
Current Liability 
         
653,030,342.00  
    
1,249,870,995.00  
        
870,491,081.00  
     
607,382,711.00  
Shareholders' Equity      
537,505,033.00  
      
506,321,664.00  
      
504,220,721.00  
    
141,110,225.00  
Current Ratio 
Current Ratio establishes the relationship between current Assets and current 
Liabilities. It attempts to measure the ability of a firm to meet its current obligations. In 
order to compute this ratio, the following formula is used : 
 
Current ratio (Working capital ratio) = Current assets / Current liabilities  
                                                                                                 [: or times or X form] 
Particulars 2014 2013 2012 2011 
Current Ratio 1.22:1 0.67:1 0.51:1 0.52:1 
 
The ideal current ratio is 2: 1. It indicates that current assets double the current liabilities 
is considered to be satisfactory. Higher value of current ratio indicates more liquid of the 
firm's ability to pay its current obligation in time. On the other hand, a low value of 
current ratio means that the firm may find it difficult to pay its current ratio as one which 
is generally recognized as the patriarch among ratios. 
 
Advantages of Current Ratios: 
(1) Current ratio helps to measure the liquidity of a firm. 
(2) It represents general picture of the adequacy of the working capital position of a 
company. 
(3) It indicates liquidity of a company. 
(4) It represents a margin of safety, i.e., cushion of protection against current creditors. 
(5) It helps to measure the short-term financial position of a company or short-term 
solvency of a firm. 
 
Disadvantages of Current Ratio: 
( 1) Current ratios cannot be appropriate to all businesses it depends on many other 
factors. 
(2) Window' dressing is another problem of current ratio, for example, overvaluation of 
closing stock. 
(3) It is a crude measure of a firm's liquidity only on the basis Of quantity and not quality 
of current assets. 
 
 
 
 
 
The current ratio measures the company’s ability to pay off its current liability. Here we 
can see that current ratio was highest in 2014 with compare in previous years. The 
statistics indicates a good liquidity position of the company. They have enough cash in 
hand to meet the short term liabilities. But it also denotes that company has huge idle 
money, so it is not good sign for the JMI. So in a concluding note I would like to say 
company should utilize their idle money in a profitable manner. 
 
 
Quick Ratio 
 
Quick Ratio also termed as Acid Test or Liquid Ratio. It is supplementary to the current 
ratio. The acid test ratio is a more severe and stringent test of a firm's ability to pay its 
short-term obligations 'as and when they become due. Quick Ratio establishes the 
relationship between the quick assets and current liabilities. In order to compute this 
ratio, the below presented formula is used : 
 
Quick asset or Acid test ratio = Quick assets / Current liabilities [: or times or X form] 
 
Particulars 2014 2013 2012 2011 
Quick Ratio 0.49:1   0.33:1   0.17:1   0.14:1  
 
The ideal Quick Ratio of 1:1 is considered to be satisfactory. High Acid Test Ratio is an 
indication that the firm has relatively better position to meet its current obligation in time. 
On the other hand, a low value of quick ratio exhibiting that the firm's liquidity position is 
not good. 
 
Advantages 
(I) Quick Ratio helps to measure the liquidity position of a firm. 
(2) It is used as a supplementary to the current ratio. 
(3) It is used to remove inherent defects of current ratio. 
We know this ratio show’s a firm’s ability to cover its current liabilities with its most liquid 
asset. This ratio concentrates on more liquid assets like cash and marketable securities. 
we can say that although JMI's ability to meet the current liabilities was below the 
standard level, they successfully managed to overcome their shortcoming and the 
statistics suggest that they are now in a good position to cover current liabilities with 
their current assets. 
 
 
Gross Profit Margin 
 
Gross Profit Margin established the relationship between gross profit and net sales. This 
ratio is calculated by dividing the Gross Profit by Sales. It is usually indicated as 
percentage. The below presented formula is used 
 
Gross Profit Margin = Gross Profit / Net Sales [%] 
Particulars 2014 2013 2012 2011 
Gross Profit Margin  5.43 X   5.67 X   4.51 X   9.19 X  
 
Higher Gross Profit Ratio is an indication that the firm has higher profitability. It also 
reflects the effective standard of performance of firm's business. Higher Gross Profit 
Ratio will be result of the following factors. 
 
(1) Increase in selling price, i.e., sales higher than cost of goods sold. 
(2) Decrease in cost of goods sold with selling price remaining constant. 
(3) Increase in selling price without any corresponding proportionate increase in cost. 
(4) Increase in the sales mix. 
 
A low gross profit ratio generally indicates the result of the following factors : 
 
(l) Increase in cost of goods sold. 
(2) Decrease in selling price. 
(3) Decrease in sales volume. 
(4) High competition. 
(5) Decrease in sales mix. 
 
Advantages 
(1) It helps to measure the relationship between gross profit and net sales. 
(2) It reflects the efficiency with which a firm produces its product. 
(3) This ratio tells the management, that a low gross profit ratio may indicate 
unfavorable purchasing and mark-up policies. 
(4) A low gross profit ratio also indicates the inability of the management to increase 
sales. 
 
 
Gross margin ratio is used to analyze how efficiently a company is using its materials, 
labor and manufacturing related fixed assets to generate profits. A higher gross margin 
percentage is a favorable profit indicator and vice-versa. This ratio helps organization to 
fix their product price. If the ratio minimum percentage then indicates the product market 
price lower or product production cost high. Here we see that gross margin ratio was not 
quite stable and it is not good sign JMI Ltd. 
 
Operating Profit Ratio 
 
Operating Profit Ratio indicates the operational efficiency of the firm and  is a measure 
of the firm's ability to cover the total operating expenses. Operating Profit Ratio can be 
calculated as : 
 
Operating profit margin = Operating profit / Sales revenue [%] 
Particulars 2014 2013 2012 2011 
Operating Profit Ratio 22.19% 21.91% 21.51% 21.41% 
 
Net Profit Margin 
Net Profit Ratio is also termed as Sales Margin Ratio (or) Profit Margin Ratio (or) Net 
Profit to Sales Ratio. This ratio reveals the firm's overall efficiency in operating the 
business. Net profit Ratio is used to measure the relationship between net profit (either 
before or after taxes) and sales. This ratio can be calculated by the following formula : 
 
Net profit margin = Net profit / Sales revenue [%] 
Particulars 2014 2013 2012 2011 
Net Profit Margin 4.09% 3.86% 4.77% 2.33% 
 
Net profit includes non-operating incomes and profits. Non-Operating Incomes such as 
dividend received, interest on investment, profit on sales of fixed assets, commission 
received, discount received etc. Profit or Sales Margin indicates margin available after 
deduction cost of production, other operating expenses, and income tax from the sales 
revenue. Higher Net Profit Ratio indicates the standard performance of the business 
concern. 
 
 
 
Advantages 
(1) This is the best measure of profitability and liquidity. 
(2) It helps to measure overall operational efficiency of the business concern. 
(3) It facilitates to make or buy decisions. 
(4) It helps to determine the managerial efficiency to use a firm's resources to generate 
income on its invested capital. 
(5) Net profit Ratio is very much useful as a tool of investment evaluation. 
Net income to sales ratio is very important in operating performance measurement. This 
ratio is helpful in identifying the proportion of sales unit that remains after the deduction 
of all expenses. This ratio indicates the net amount of profit on each sales taka. The 
amount of net income includes all types of non operating items that may occur in a 
particular period. The ratio dropped in 2013, then increase in 2014. As a result company 
has generated more profit. 
 
Return on Investment Ratio 
This ratio is also called as ROI. This ratio measures a return on the owner's or 
shareholders' investment. This ratio establishes the relationship between net profit after 
interest and taxes and the owner's investment. Usually this is calculated in percentage. 
This ratio, thus. can be calculated as : 
 
Return on investment (ROI) or Return on assets (ROA) = Net income / Total assets [%] 
Particulars 2014 2013 2012 2011 
Return on Investment 2.24% 1.47% 1.58% 1.01% 
 
Advantages 
(1) This ratio highlights the success of the business from the owner's point of view. 
(2) It helps to measure an income on the shareholders' or proprietor's investments. 
(3) This ratio helps to the management for important decisions making. 
(4) It facilitates in determining efficiently handling of owner's investment. 
 
 
 
 
Return on total Investment indicates how profitable a company is relative to its total 
assets. It also indicates the management efficiency to utilize total assets to make profit. 
In 2014 it has been increased compared to the previous year. So it can be said that 
company generates 1.01%, 1.58%, 1.47%, and 2.24% return on the assets that it 
employs in its operations in this four year time period. 
 
Earnings Per Share 
Earnings Per Share Ratio (EPS) measures the earning capacity of the concern from the 
owner's point of view and it is helpful in determining the price of the equity share in the 
market place. Earnings Per Share Ratio can be calculated as : 
 
Earnings Per Share = Net Profit / No. of Share 
Particulars 2014 2013 2012 2011 
Earnings Per Share 4.46 2.95 1.12 1.05 
 
Advantages 
(1) This ratio helps to measure the price of stock in the market place. 
(2) This ratio highlights the capacity of the concern to pay dividend to its shareholders. 
(3) This ratio used as a yardstick to measure the overall performance of the concern. 
Shareholders are mostly concern about earning per share (EPS), because EPS is 
widely used indicator in investment decision. In 2011 EPS was TK. 1.05 but in next two 
years it is increasing day by day. JMI Ltd. in 2014 EPS it reaches 4.46 TK. It’s good sign 
for company reputation and investors will be interested to invest on the company. 
 
Inventory Turnover Ratio 
Inventory means stock of raw materials, working in progress and finished goods. This 
ratio is used to measure whether the investment in stock in trade is effectively utilized or 
not. It reveals the relationship between sales and cost of goods sold or average 
inventory at cost price or average inventory at selling price.   
Inventory Turnover Ratio indicates the number of times the stock has been turned over 
in business during a particular period. In order to compute this ratio, the following 
formula is used : 
 
 
 
Inventory turnover = Cost of goods sold / Average inventory [times or X form] 
 
Particulars 2014 2013 2012 2011 
Inventory Turnover  1.75 times   1.33 times   1.37 times   2.21 times  
 
Advantages  
(1) This ratio indicates whether investment in stock in trade is efficiently used or not. 
(2) This ratio is widely used as a measure of investment in stock is within proper limit or 
not. 
(3) This ratio highlights the operational efficiency of the business concern. 
(4) This ratio is helpful in evaluating the stock utilization. 
(5) It measures the relationship between the sales and the stock in trade. 
(6) This ratio indicates the number of times the inventories have been turned over in 
business during a particular period. 
 
Inventory turnover ratio measures how fast the inventory become cash or accounts 
receivable. If the turnover number is more than the company’s position is good and vice 
versa.  In 2014 it is 1.75 times and in 2013 is 1.33 times in 2012 it is 1.37 times in 2011 
it is 2.21. Here we see the turnover is increasing over the time. It shows a positive 
impact on their management efficiency but the speed is very slow .It should be more 
fast. 
 
 
Fixed Assets Turnover Ratio 
 
This ratio indicates the efficiency of assets management. Fixed Assets Turnover Ratio 
is used to measure the utilization of fixed assets. This ratio establishes the relationship 
between cost of goods sold and total fixed assets. Higher the ratio highlights a firm has 
successfully utilized the fixed assets. If the ratio is depressed, it indicates the under 
utilization of fixed assets. The ratio may also be calculated as: 
 
Fixed asset turnover = Sales revenue / Fixed assets [: or times or X form] 
Particulars 2014 2013 2012 2011 
Fixed Asset Turnover  0.86 times  0.61 times 0.45 times 0.61 times 
 
 
 
 
 
 
Total Asset Turnover Ratio 
 
The asset turnover ratio is an efficiency ratio that measures a company's ability to 
generate sales from its assets by comparing net sales with average total assets. In 
other words, this ratio shows how efficiently a company can use its assets to generate 
sales. 
 
Total assets turnover = Sales revenue / Total assets [: or times or X form] 
Particulars 2014 2013 2012 2011 
Total Asset Turnover  0.55 times   0.38 times   0.33 times   0.44 times  
 
Here was see that total assets turnover has increased over time. Sales and total assets 
increase in 2013 & 2014. But compare to 2011 and 2012; ratio is slightly dropped in 
2012. After that it was recovered marginally. 
 
 
Debt Equity Ratio 
 
This ratio also termed as External - Internal Equity Ratio. This ratio is calculated to 
ascertain the firm's obligations to creditors in relation to funds invested by the owners. 
The ideal Debt Equity Ratio is 1: 1. This ratio also indicates all external liabilities to 
owner recorded claims. It may be calculated as 
 
Debt-equity ratio = Total debt / Total equity [: or times or X form] 
Particulars 2014 2013 2012 2011 
Debt Equity Ratio  2.34 times   2.79 times   1.98 times   5.68 times  
 
 
Debt Ratio 
 
A financial ratio that measures the extent of a company’s or consumer’s leverage. The 
debt ratio is defined as the ratio of total debt to total assets, expressed in percentage, 
and can be interpreted as the proportion of a company’s assets that are financed by 
debt. It may be calculated as 
 
 
 
 
Debt ratio = Total debt / Total assets [%] 
Particulars 2014 2013 2012 2011 
Debt Ratio 59.80% 63.90% 57.34% 70.22% 
 
We can see that the debt to total asset ratio is decreasing year to year. It seems they 
are expanding their asset and these asset expansions are supported not fully by the 
debt financing. So this decreasing trend is not so bad for the company. 
 
 
Return on Equity 
 
ROE is a profitability ratio that measures the ability of a firm to generate profits from its 
shareholders investments in the company. In other words, the return on equity ratio 
shows how much profit each dollar of common stockholders' equity generates. 
Return on equity (ROE) = Net income available for common stockholders’ / Common 
equity [%] 
Particulars 2014 2013 2012 2011 
Return on Equity 9.11% 6.40% 5.46% 8.20% 
 
A  return on 1 means that every dollar of common stockholders' equity generates 1 
dollar of net income. This is an important measurement for potential investors because 
they want to see how efficiently a company will use their money to generate net income. 
ROE is also an indicator of how effective management is at using equity financing to 
fund operations and grow the company. 
Return on equity measures how efficiently a firm can use the money from shareholders 
to generate profits and grow the company. Unlike other return on investment ratios, 
ROE is a profitability ratio from the investor's point of view not the company.  
 
Return on equity is the measurement of shareholders wealth maximization. It indicates 
how much shareholders earned from their investment. The higher the ratio indicates 
higher the shareholders wealth maximization. Return on equity is highest in 2014 return 
shows 9.11%. So it’s good news for JMI Ltd. that its present ROE is better than 
previous year. 
 
 
 
Accounts Receivable Turnover Ratio 
 
Accounts receivable turnover is the number of times per year that a business collects its 
average accounts receivable. The ratio is intended to evaluate the ability of a company 
to efficiently issue credit to its customers and collect funds from them in a timely 
manner. 
 
Accounts receivable turnover = Credit sales / Average accounts receivable [times or X   
form] 
Particulars 2014 2013 2012 2011 
Receivable Turnover  9.18 times   4.61 times   10.13 times   17.54 times  
 
A high turnover ratio indicates a combination of a conservative credit policy and an 
aggressive collections department, as well as a number of high-quality customers.  
A low turnover ratio represents an opportunity to collect excessively old accounts 
receivable that are unnecessarily tying up working capital. Low receivable turnover may 
be caused by a loose or nonexistent credit policy, an inadequate collections function, 
and/or a large proportion of customers having financial difficulties.  
 
This ratio shows the number of times accounts receivables have been turned into cash 
during the year. In 2011 the ratio was good. But in the next year it decreased and for the 
last three years it fluctuated around the number 10. I think the range is satisfactory for 
the company.  
 
 
Net Asset Value Per Share 
 
The net asset value per share can be defined as an expression for net asset value that 
indicates the value per share for a fund (exchange-traded, mutual, and closed-end) or a 
company. 
 
Net Asset Value Per Share = Total Equity / No. of Share 
 
Particulars 2014 2013 2012 2011 
Net Asset Value Per Share 48.86 46.03 45.84 12.83 
 
 
 
Findings of the report 
 
Financial Ratio Analysis also referred to as 'Quantitative Analysis' is considered to be 
the most important step while analyzing a company from an investment  perspective. It 
is a study of ratios between various items in financial statements. Ratios are classified 
as profitability ratios, liquidity ratios, asset utilization ratios, leverage ratios and valuation 
ratios based on the indications they provide. Balance sheet, Income Statement and 
Cash Flow Statements are the most important financial statements and if properly 
analyzed and interpreted can provide valuable insights into a company's business. 
Financial Ratios is commonly used by current and potential investors, creditors and 
financial institutions to evaluate a company's past performance to spot trends in a 
business and to compare its performance with the average industry performance. It also 
enables them to identify strengths and weaknesses of a business and to justify further 
investments in the business. Internally, managers use these ratios to monitor 
performance and to set specific goals, objectives, and policy initiatives. These are the 
most common questions any investor has in his mind when he looks at the financial 
statements of a company he plans to invest in. While massive amount of numbers in a 
financial statement may be bewildering and intimidating to a layman investor, Financial 
Ratio Analysis enables him to understand these numbers in an organized fashion. 
The most important assumption the analyst should make sure while drawing 
conclusions based on financial ratios is that the accounting policy of the company has 
remained constant over the period of review. Changes in accounting policies may distort 
the indications provided by the ratios. For example, companies that intend to enhance 
their asset return ratios may change the depreciation accounting method applied; thus 
providing misleading asset return ratios. The analyst should therefore make 
adjustments for any material differences in accounting policies before evaluating ratios. 
Similarly, it is equally important to allow for any material differences in accounting 
policies while comparing the company with other industry players. 
While ratios do provide valuable insight into the company's past performance and 
potential problems, they cannot be evaluated on a standalone basis. For a thorough 
examination of a business, the analyst must read between the lines and check for any 
major fluctuations in any line item in financial statements. Nonrecurring items and extra-
ordinary expense or income items must be excluded for meaningful analysis. Similarly, 
wide fluctuations in revenue figure or expense figure should be justified. Here the 
importance of Note to financial statements cannot be overemphasized. Information 
provided in these notes to financial statements can be very helpful in avoiding 
inappropriate investment decisions due to misleading financial ratios. 
 
 
 
Major’s findings of the report are as follows 
 
 The employees of departments of JMI Syringes are very much co-operative 
and interdependent to each other. 
 JMI provides a complete set of financial statements includes a balance sheet, 
an income statement, a cash flow statement, a statement showing either all 
changes in equity or changes in equity other than those arising from 
investments by and distributions to owners, a summary of accounting policies, 
and explanatory notes. 
 There are positive relationship exists among assets, sales and net income. 
 Finance and Accounting department is one of the most important departments 
of JMI Syringes, they are responsible to make profit for the organization. 
 The portion of debt in total asset and time interest earned is increasing. 
 The equity value per share of JMI is less than its current market price per 
share. 
 The operating expenses of JMI Syringes have dramatically increased for the 
last few years, which has a significant influence to lower the net income 
 The entire department should be well informed regarding their goal and 
objectives. It is essential to execute company objective into individual target. 
 There must be clear allocation of responsibilities , authority and accountability. 
 The company should introduce more promotional activities. 
 The company should take initiative to develop an effective research and 
development centre to get innovative ideas to capture the competitive market. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Particulars 2014 2013 2012 2011 
Current Ratio 1.22:1 0.67:1 0.51:1 0.52:1 
Quick Ratio  0.49:1   0.33:1   0.17:1   0.14:1  
Return on Equity 9.11% 6.40% 5.46% 8.20% 
Inventory Turnover  1.75 times   1.33 times   1.37 times   2.21 times  
Receivable Turnover  9.18 times   4.61 times   10.13 times   17.54 times  
Fixed Asset Turnover  0.86 times  0.61 times 0.45 times 0.61 times 
Net Asset Value Per Share                    48.86                      46.03                      45.84                    12.83  
Earnings Per Share                      4.46                       2.95                        1.12                      1.05  
Return on Investment 2.24% 1.47% 1.58% 1.01% 
Total Asset Turnover  0.55 times   0.38 times   0.33 times   0.44 times  
Operating Profit Margin 22.19% 21.91% 21.51% 21.41% 
Net Profit Margin 4.09% 3.86% 4.77% 2.33% 
Debt Ratio 59.80% 63.90% 57.34% 70.22% 
Debt Equity Ratio  2.34 times   2.79 times   1.98 times   5.68 times  
Gross Profit Margin  5.43 X   5.67 X   4.51 X   9.19 X  
 
 
  Conclusion 
 
In Bangladesh, Surgical Device & Pharmaceutical sector is one of the most 
developed hi-tech sectors which are contributing in the country’s economy. 
Pharmaceutical sector is one of the fastest growing and most developed scientific 
sectors in Bangladesh.    As a surgical device company JMI has wonderful chance to 
do well and go to the number one position in this industry. They have lots of prospect 
like AD syringe, Urine Bag & First Aid Bandage etc. But the management body 
should consider some other issues like bank loan, operating expense, project 
finance, investments and so on. Otherwise all the success achieved by the company 
in recent years can go to vein. So the company should deep concern on the above 
issue and take necessary to built strong position in surgical device market in 
Bangladesh. 
 
 
 
 
 
 
 
Recommendation 
 
The overall performance of JMI shows a satisfactory position although they are 
suffering last few years. It is not easy to recommend some suggestion to enhance 
the performance level of the organization. 
 I have observed some shortcoming regarding operational and other aspects. On the 
basis of my observation I would like to present the following recommendations: 
 Though JMI has qualified employee in Finance and Accounting department, 
but the organization should recruit some new employee to run this department 
smoothly. 
 JMI should increase their equity capital in their capital structure, because debt 
capital is already higher. 
 JMI should utilize their assets properly by investing them in more profitable 
projects as there liquidity is higher than actual need. 
 They should increase dividend per share that will serve as a promotional tool. 
 Contribution analysis for each of the product lines to optimize profit in light of 
demand factors. 
 Effects to bring selling prices in line with costs having regard to competition 
and other market factors. 
 They should minimize their financing expenses to make higher net profit.  
 They should maximize the average collection period and average payable 
period. 
 They should be careful about the market price of share, because the price of 
share would decrease in future. 
 Standard set-up for staff and officers to minimize administrative overhead. 
 Provision for the training of officers and employees in modern management 
techniques. 
 Necessary measures to be taken for the prompt seminars, advertisement and 
promotional activities by the representatives. 
      In the face of today’s global competition with open market operation, JMI must 
develop and retain the high achievers and motivated work force and equip them with 
the latest skills and technologies. 
 
 
 
 
 
 
 
 
Bibliography: 
 Annual Report of JMI Syringes & Medical Devices Limited – 2011 - 2012 - 2013 - 2014 
 Newspaper, Journal, Magazine 
 Bangladesh Association of Pharmaceutical Industries 
 World Pharmaceutical Association 
 Fundamentals of Financial Management, by Brigham and Houston 
 Annual Reports Square Pharmaceuticals Ltd. 
 Annual Reports Incepta Pharmaceuticals Ltd. 
 Annual Reports Renata Pharmaceuticals Ltd. 
 Annual Reports Beximco Pharmaceuticals Ltd. 
 
Web-site: 
 
 http//www.wikipedia.org      
 http//www.pharmaceutical-industry.info 
 http://ims-global.com 
 http://www.dse.com. 
 http://www.jmigroup-bd.com/  
 http://www.bijoy.net/demo/demo_site/opso/opso.html  
 http://www.dgfp.gov.bd/  
 www.cambridge.org 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
